首页 > 市场调查报告书 > 医疗设备

伤口护理

市场调查报告书

商品编码

1629889

全球先进伤口护理与闭合市场 - 2025-2033

Global Advanced Wound Care and Closure Market - 2025-2033

出版日期: 2024年12月30日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2023年，全球先进伤口护理和闭合市场规模达到215亿美元，预计2033年将达到345亿美元，2025-2033年预测期间复合年增长率为4.8%。

高级伤口护理和闭合是一个专门的医疗保健领域，专注于使用创新产品和技术来治疗和管理急性和慢性伤口。它涉及使用泡沫、水胶体、藻酸盐和抗菌剂等敷料来创造最佳的癒合环境，预防感染并促进组织再生。缝合线、钉书钉、组织黏合剂和止血剂等医疗解决方案用于安全闭合伤口并支持自然癒合过程。这些先进的解决方案提供有针对性的治疗，以促进康復、最大限度地减少併发症并改善患者的治疗效果。它对于处理慢性伤口、手术伤口、外伤和烧伤病例至关重要。

市场动态：

驱动程式和限制

慢性伤口盛行率上升

由于糖尿病、肥胖和血管疾病引起的慢性伤口（例如糖尿病足溃疡、静脉性腿部溃疡和压疮）的盛行率不断增加，全球先进伤口护理和闭合市场正在蓬勃发展。这些情况会损害伤口的自然癒合过程，因此需要先进的解决方案。人口老化推动了对泡沫敷料、水胶体和抗菌敷料等创新伤口护理产品的需求，由于皮肤弹性下降和再生能力较慢，老年人更容易患慢性伤口。这些产品提供最佳的水分平衡，降低感染风险，促进更快的癒合，进而推动全球市场的成长。

例如，根据 Uintah Basin Healthcare 的数据，近 70 亿美国人患有慢性伤口，其中 20 亿人患有糖尿病足溃疡。四分之一的家庭有一名家庭成员患有慢性伤口。长期不癒合的伤口会增加感染、住院或截肢的风险。随着人口老化以及肥胖、糖尿病和心臟病等疾病的增加，伤口护理的普及率预计在未来 5-10 年内每年将以 2% 的速度增长。

医疗保健专业人员的意识和培训有限

全球先进伤口护理和闭合市场因医疗保健专业人员的意识和培训有限而受到阻碍，特别是在发展中国家。由于缺乏对先进伤口护理产品及其应用的接触，经常使用传统方法。这阻碍了生物活性敷料、组织工程产品和先进闭合装置等创新解决方案的采用。一些先进伤口护理技术的复杂性需要专门的训练。培训计划不足和获得教育资源的机会有限加剧了这种知识差距，阻碍了先进伤口护理产品的渗透并影响患者护理质量，最终减缓了市场的成长潜力。

Advanced wound care and closure is a specialized healthcare field that focuses on treating and managing acute and chronic wounds using innovative products and techniques. It involves the use of dressings like foam, hydrocolloid, alginate, and antimicrobial to create optimal healing environments, prevent infections, and promote tissue regeneration. Medical solutions like sutures, staples, tissue adhesives, and hemostatic agents are used to securely close wounds and support the natural healing process. These advanced solutions offer targeted therapies to enhance recovery, minimize complications, and improve patient outcomes. It is crucial for managing chronic wounds, surgical wounds, traumatic injuries, and burn cases.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Chronic Wounds

The global advanced wound care and closure market is thriving due to the increasing prevalence of chronic wounds, such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers, caused by diabetes, obesity, and vascular diseases. These conditions impair the natural wound healing process, necessitating advanced solutions. The demand for innovative wound care products, such as foam dressings, hydrocolloids, and antimicrobial dressings, is fueled by the aging population, who are more susceptible to chronic wounds due to reduced skin elasticity and slower regenerative capacity. These products provide optimal moisture balance, reduce infection risks, and promote faster healing, thereby driving market growth globally.

For instance, according to Uintah Basin Healthcare, Nearly 7 Billion Americans suffer from chronic wounds, including 2 Billion with diabetic foot ulcers. 1 in 4 families has a family member with a chronic wound. Long-term non-healing wounds increase the risk of infection, hospitalization, or amputation. As the population ages and conditions like obesity, diabetes, and heart disease increase, the prevalence of wound care is expected to grow by 2% per year over the next 5-10 years.

Limited Awareness and Training among Healthcare Professionals

The global advanced wound care and closure market is hindered by limited awareness and training among healthcare professionals, particularly in developing countries. Traditional methods are often used due to a lack of exposure to advanced wound care products and their applications. This prevents the adoption of innovative solutions like bioactive dressings, tissue-engineered products, and advanced closure devices. The sophisticated nature of some advanced wound care technologies requires specialized training. Inadequate training programs and limited access to educational resources exacerbate this knowledge gap, hindering the penetration of advanced wound care products and affecting patient care quality, ultimately slowing the market's growth potential.

Segment Analysis

The global advanced wound care and closure market is segmented based on product type, wound type, end user and region.

Product Type:

Foam Dressing segment from advanced wound care products is expected to dominate the Advanced Wound Care and Closure market share

The foam dressing segment from advanced wound care products holds a major portion of the advanced wound care and closure market share and is expected to continue to hold a significant portion of the advanced wound care and closure market share during the forecast period.

Foam dressings are a crucial component in the global wound care and closure market, providing a moist environment for managing various wounds. They are highly absorbent, ideal for moderate to heavy exudate wounds like diabetic foot ulcers and pressure ulcers. They offer cushioning, protection, and minimize pain during dressing changes. Foam dressings are versatile, suitable for both hospital and home care settings, driving their global adoption. The increasing prevalence of chronic conditions like diabetes and obesity, along with the increasing number of surgeries worldwide, contribute to the growing demand for foam dressings. Their ease of use, high performance, and cost-effectiveness make them a cornerstone in advanced wound care, enhancing patient outcomes and accelerating the market's growth.

For instance, in January 2023, Smith+Nephew has published data on its ALLEVYN LIFE Dressing, which shows a novel mechanism of action for pressure injury prevention (PIP). The study, published in the International Wound Journal, found that the dressing's independent and non-bonded internal layers allow for a layer-on-layer sliding phenomenon, allowing for the dissipation of mechanical energy that could otherwise be transferred to the patient. This results in the layer-on-layer frictional sliding of ALLEVYN LIFE Dressing absorbing 30-45% of the mechanical energy, potentially reducing pressure injury incidence in the patient's skin and underlying soft tissues.

End User:

Hospitals segment is the fastest-growing segment in Advanced Wound Care and Closure market share

The hospitals segment is the fastest-growing segment in the advanced wound care and closure market share and is expected to hold the market share over the forecast period.

Hospitals are the primary treatment centers for complex and chronic wounds, including diabetic foot ulcers, surgical wounds, pressure ulcers, and burn injuries. The growing number of hospital admissions for these conditions and the increasing incidence of surgeries and trauma cases fuel the demand for advanced wound care solutions.

Moreover, hospitals are equipped with the necessary infrastructure and expertise to administer advanced wound care therapies, such as bioactive dressings, hydrocolloids, and tissue-engineered products. Adoption of minimally invasive wound closure technologies, such as tissue adhesives and hemostatic agents, supports faster healing and reduces recovery times, enhancing patient outcomes. The extensive use of advanced wound care products in hospitals boosts their availability and accelerates innovation in wound management solutions, making them a key driver in the market's growth.

Geographical Analysis

North America is expected to hold a significant position in the Advanced Wound Care and Closure market share

North America holds a substantial position in the advanced wound care and closure market and is expected to hold most of the market share due to its established healthcare infrastructure, high healthcare funding, and advanced medical technology adoption. The US is particularly affected by chronic conditions like diabetes, obesity, and cardiovascular diseases, leading to chronic wounds like diabetic foot ulcers and pressure ulcers. The increasing number of surgical procedures and aging population further increase the need for advanced wound closure solutions. The region's strong regulatory framework ensures product safety and efficacy, fostering consumer confidence and market growth. Additionally, reimbursement policies for advanced wound care products enhance their adoption by healthcare providers and patients, contributing significantly to the market's growth.

For instance, in January 2024, 3M Health Care's Medical Solutions Division has been awarded $34.2 Billion from the U.S. Army Medical Research Acquisition Activity to develop new infection prevention, wound management, and wound healing solutions. The program will focus on treatment strategies for austere settings, particularly mass casualty and delayed evacuation situations, as part of the Department of Defense Combat Casualty Care Capability Assessment. It will also assess biofilm control, biomarker monitoring, and healing in acute trauma situations.

Moreover, in September 2024, Solventum has launched the V.A.C. Peel and Place Dressing, an integrated dressing and drape that can be applied in less than two minutes and worn by patients for up to seven days. This is a significant improvement over traditional dressings for negative pressure wound therapy, which typically take more than two hours to apply.

Asia-Pacific is growing at the fastest pace in the Advanced Wound Care and Closure market

Asia-Pacific holds the fastest pace in the advanced wound care and closure market and is expected to hold most of the market share due to the due to economic development, improved healthcare infrastructure, and increased healthcare awareness. The rising incidence of chronic diseases like diabetes and hypertension, as well as the aging population in countries like China, India, and Japan, are driving demand for these solutions. However, challenges such as limited awareness and training among healthcare professionals persist, especially in rural areas. Despite these obstacles, the increasing number of healthcare facilities, rising disposable income, and government healthcare investments present significant opportunities for the advanced wound care market in the APAC region.

For instance, in July 2024, AMS BioteQ, a biotech company, has obtained a first-class medical device sales permit from Japan's PMDA for its "SIPSIP Foam Wound Dressing," a medical device with excellent anti-adhesion properties, high absorbency, and tissue regeneration capabilities. This is the first Taiwanese "cotton-based wound dressing" medical device to receive approval in Japan, marking a milestone in AMS BioteQ's global market expansion for its self-developed brand.

Competitive Landscape

The major global players in the advanced wound care and closure market include 3M Company, Integra LifeSciences Holdings Corporation, Baxter International Inc., Johnson & Johnson, Convatec Group plc, Essity Aktiebolag AB, Coloplast, Medtronic plc, B. Braun SE, Smith and Nephew plc and among others.

Key Developments

In August 2023, Healthium Medtech has launched TRUMASTM, a range of sutures designed to address challenges in minimal access surgeries. As India celebrates its 77th year of Independence, Healthium reaffirms its commitment to innovation in the Indian medtech landscape by introducing a revolutionary solution for suturing during minimal access procedures.

Emerging Players

The emerging players in the advanced wound care and closure market include KCI licensing, Inc, MiMedx Group, Inc, Organogenesis Holdings Inc, Axio Biosolutions, Hemostatix Medical Technologies, LLC and among Others.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global advanced wound care and closure market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Wound Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Wound Type
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Prevalence of Chronic Wounds
- 4.1.2. Restraints
  - 4.1.2.1. Limited Awareness and Training among Healthcare Professionals
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Advanced Wound Care *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 6.2.3. Foam Dressings
- 6.2.4. Hydrocolloid Dressings
- 6.2.5. Hydrogel Dressings
- 6.2.6. Alginate Dressings
- 6.2.7. Collagen Dressings
- 6.2.8. Antimicrobial Dressings
- 6.2.9. Film Dressings
6.3. Wound Closure
- 6.3.1. Sutures
- 6.3.2. Hemostatic Agents
- 6.3.3. Staples
- 6.3.4. Tissue Adhesives, Sealants, and Glues

7. By Wound Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
- 7.1.2. Market Attractiveness Index, By Wound Type
7.2. Acute Wounds*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Chronic Wounds

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Surgical Centers (ASCs)
8.4. Home Healthcare
8.5. Specialty Clinics

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. 3M Company *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Integra LifeSciences Holdings Corporation
11.3. Baxter International Inc
11.4. Johnson & Johnson
11.5. Convatec Group plc
11.6. Essity Aktiebolag AB
11.7. Coloplast
11.8. Medtronic Plc
11.9. B. Braun SE
11.10. Smith and Nephew Plc

LIST NOT EXHAUSTIVE